Liang Steven H
Department of Radiology and Imaging Sciences, Emory University Atlanta, Georgia 30322, United States.
Am J Nucl Med Mol Imaging. 2025 Jun 25;15(3):105-108. doi: 10.62347/GHKA7738. eCollection 2025.
Trop2 is overexpressed in various tumors and serves as a key biomarker. Targeted immunoPET ligands, mainly developed from Trop2 monoclonal antibodies and nanobodies, provide the landscape of heterogeneous expression of Trop2 in tumors, which has great potential in improving accuracy of cancer diagnosis and staging, as well as decision-making in therapy.
Trop2在多种肿瘤中过表达,是一种关键生物标志物。主要由Trop2单克隆抗体和纳米抗体开发而来的靶向免疫正电子发射断层显像(immunoPET)配体,展现了Trop2在肿瘤中异质性表达的情况,这在提高癌症诊断和分期的准确性以及治疗决策方面具有巨大潜力。